Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Keel Infrastructure Corp. (KEEL)
NASDAQFinancialsInformation Technology ServicesSnapshot 2026-11-04
$1.65-21.67%
Close 2026-11-05 · 1-day change
NASDAQFinancialsInformation Technology ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for KEEL yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Effective management of capital through debt issuance | A supporting condition in Keel Infrastructure Corp.'s published investment case. The stated target is Maintain capital allocation strategy with convertible notes. | Intact | fails to issue planned convertible notes | Convertible notes issued: $458M vs target of planned issuance June 2026 8-K confirms issuance of $458M convertible notes, meeting the thesis requirement for debt issuance. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, loss-making business rather than an established compounder. Its thesis state is watch: recent performance is weak, risk is elevated, and confidence in the evidence is low.
KEEL carries a 5.43% premium versus peers, while the model shows a negative expectations gap and low confidence. The valuation tag is justified and fragility is low, but the evidence does not show that this premium reflects improving business results.
Near term, the latest evidence points to continued pressure: revenue fell from $37.0 million in 2026-Q1 to $30.4 million in 2026-Q2, while operating losses widened from $98.4 million to $140.8 million. Management has followed through on issuing convertible notes, but progress on reducing losses is limited, and the recent earnings miss and leadership transition add uncertainty.
Over the next few quarters, the key test is whether revenue stabilizes and operating losses narrow. The broader sector backdrop may help if financial-sector bellwethers keep beating earnings and raising guidance, while falling interest rates or weaker bellweller results could remove that support.
For a 1-to-3-year view, KEEL remains a low-confidence, loss-making thesis that depends on better operating results and favorable sector conditions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 3 of last 3 quarters. The company announced intentions to issue $350 million in convertible notes in 2026-Q1 and completed issuance of $458 million in 2026-Q2, becoming co-obligor under the note indenture in 2025-Q4. The trajectory shows active capital allocation through debt issuance, delivering on stated priorities.
Operating losses must decrease to show financial improvement | The company aims to reduce operating losses and increase revenue. | Broken | operating losses exceed -$98.4 million for FY26 | Operating income: $-140.774M FY2026-Q2; GAAP. Published target: <= -$98.4 million for FY26. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 2026-140,774,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of last 2 quarters. Operating losses increased from $98.4 million in 2026-Q1 to $140.8 million in 2026-Q2 while revenue declined from $37.0 million to $30.4 million. The financial trajectory shows worsening losses and declining revenue, indicating limited progress on improving financial performance. Delivery assessment Oct 31, 2026 |
Revenue growth must improve to stabilize the business | A primary condition in Keel Infrastructure Corp.'s published investment case. The stated target is >= $105.8 million for FY26. | Intact | revenue falls below $105.8 million for FY26 | Revenue: $30.43M FY2026-Q2; GAAP. Published target: >= $105.8 million for FY26. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 202630,430,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of last 2 quarters. Operating losses increased from $98.4 million in 2026-Q1 to $140.8 million in 2026-Q2 while revenue declined from $37.0 million to $30.4 million. The financial trajectory shows worsening losses and declining revenue, indicating limited progress on improving financial performance. Delivery assessment Oct 31, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.29 → $-0.36 · observed estimates
$0.10B → $0.09B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-27 | $-0.29 | $102,273,500 | 4 / 8 |
| 2026-08-28 | $-0.29 | $102,273,500 | 4 / 8 |
| 2026-08-29 | $-0.29 | $102,273,500 | 4 / 8 |
| 2026-08-30 | $-0.29 | $102,273,500 | 4 / 8 |
| 2026-08-31 | $-0.29 | $102,273,500 | 4 / 8 |
| 2026-09-01 | $-0.29 | $102,273,500 | 4 / 8 |
| 2026-09-02 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-03 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-04 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-05 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-06 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-07 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-08 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-09 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-10 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-11 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-12 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-13 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-14 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-15 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-16 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-17 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-18 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-19 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-20 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-21 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-22 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-23 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-24 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-25 | $-0.30 | $104,713,500 | 4 / 8 |
| 2026-09-26 | $-0.30 | $101,185,000 | 4 / 8 |
| 2026-09-27 | $-0.30 | $101,185,000 | 4 / 8 |
| 2026-09-28 | $-0.30 | $101,185,000 | 4 / 8 |
| 2026-09-29 | $-0.30 | $101,185,000 | 4 / 8 |
| 2026-09-30 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-01 | $-0.31 | $92,640,182 | 5 / 8 |
| 2026-10-02 | $-0.31 | $92,640,182 | 5 / 9 |
| 2026-10-03 | $-0.31 | $92,640,182 | 5 / 9 |
| 2026-10-04 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-05 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-06 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-07 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-08 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-09 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-10 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-11 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-12 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-13 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-14 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-15 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-16 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-17 | $-0.31 | $92,640,182 | 4 / 8 |
| 2026-10-18 | $-0.31 | $92,640,182 | 5 / 8 |
| 2026-10-19 | $-0.31 | $92,640,182 | 5 / 8 |
| 2026-10-20 | $-0.31 | $92,640,182 | 5 / 8 |
| 2026-10-21 | $-0.31 | $92,640,182 | 5 / 8 |
| 2026-10-22 | $-0.31 | $92,640,182 | 5 / 8 |
| 2026-10-23 | $-0.31 | $92,640,182 | 5 / 8 |
| 2026-10-24 | $-0.33 | $86,409,280 | 5 / 8 |
| 2026-10-25 | $-0.33 | $86,409,280 | 5 / 8 |
| 2026-10-26 | $-0.33 | $86,409,280 | 5 / 8 |
| 2026-10-27 | $-0.33 | $86,409,280 | 5 / 8 |
| 2026-10-28 | $-0.36 | $85,941,098 | 5 / 8 |
| 2026-10-29 | $-0.36 | $85,941,098 | 5 / 7 |
| 2026-10-30 | $-0.36 | $85,941,098 | 5 / 7 |
| 2026-10-31 | $-0.36 | $85,941,098 | 5 / 7 |
| 2026-11-01 | $-0.36 | $85,941,098 | 5 / 7 |
| 2026-11-02 | $-0.36 | $85,941,098 | 5 / 7 |
| 2026-11-03 | $-0.36 | $85,941,098 | 5 / 7 |
| 2026-11-04 | $-0.36 | $85,941,098 | 5 / 7 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 10 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.